Melodiol Global Health (ASX:ME1DE) Total Assets : A$19.04 Mil (As of Dec. 2023)

View and export this data going back to 2016. Start your Free Trial

What is Melodiol Global Health Total Assets?

Melodiol Global Health's Total Assets for the quarter that ended in Dec. 2023 was A$19.04 Mil.

During the past 12 months, Melodiol Global Health's average Total Assets Growth Rate was -49.80% per year. During the past 3 years, the average Total Assets Growth Rate was 12.00% per year. During the past 5 years, the average Total Assets Growth Rate was 9.20% per year.

During the past 8 years, Melodiol Global Health's highest 3-Year average Total Assets Growth Rate was 201.90%. The lowest was 11.70%. And the median was 12.50%.

Total Assets is connected with ROA %. Melodiol Global Health's annualized ROA % for the quarter that ended in Dec. 2023 was -186.66%. Total Assets is also linked to Revenue through Asset Turnover. Melodiol Global Health's Asset Turnover for the quarter that ended in Dec. 2023 was 0.46.

Melodiol Global Health Total Assets Historical Data

The historical data trend for Melodiol Global Health's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Melodiol Global Health Total Assets Chart

Melodiol Global Health Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Assets

Get a 7-Day Free Trial

22.66

19.12

29.31

37.98

19.04

Melodiol Global Health Semi-Annual Data
	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Total Assets	Get a 7-Day Free Trial										29.31	30.75	37.98	32.81	19.04

Melodiol Global Health Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Melodiol Global Health's Total Assets for the fiscal year that ended in Dec. 2023 is calculated as

Total Assets	=	Total Equity (A: Dec. 2023 )	+	Total Liabilities (A: Dec. 2023 )
	=	-4.058	+	23.102
	=	19.04

Melodiol Global Health's Total Assets for the quarter that ended in Dec. 2023 is calculated as

Total Assets	=	Total Equity (Q: Dec. 2023 )	+	Total Liabilities (Q: Dec. 2023 )
	=	-4.058	+	23.102
	=	19.04

Melodiol Global Health (ASX:ME1DE) Total Assets Explanation

Total Assets is connected with ROA %.

Melodiol Global Health's annualized ROA % for the quarter that ended in Dec. 2023 is

ROA %	=	Net Income (Q: Dec. 2023 )	/	( (Total Assets (Q: Jun. 2023 )	+	Total Assets (Q: Dec. 2023 ))	/ count )
	=	-48.39	/	( (32.805	+	19.044)	/ 2 )
	=	-48.39	/	25.9245
	=	-186.66 %

Note: The Net Income data used here is two times the semi-annual (Dec. 2023) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Melodiol Global Health's Asset Turnover for the quarter that ended in Dec. 2023 is

	Asset Turnover
=	Revenue (Q: Dec. 2023 )	/	( (Total Assets (Q: Jun. 2023 )	+	Total Assets (Q: Dec. 2023 ))	/ count )
=	11.926	/	( (32.805	+	19.044)	/ 2 )
=	11.926	/	25.9245
=	0.46

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Melodiol Global Health Total Assets Related Terms

Thank you for viewing the detailed overview of Melodiol Global Health's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Melodiol Global Health (ASX:ME1DE) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Melodiol Global Health Ltd (ASX:ME1DE) » Definitions » Total Assets

Comparable Companies

Traded in Other Exchanges

COPHF:USA

Address

145 Stirling Highway, Suite 5 CPC, Nedlands, WA, AUS, 6009

Website

https://www.cresopharma.com

Melodiol Global Health Ltd is engaged in developing, registering, and commercialization of pharmaceutical-grade cannabis and hemp-based nutraceutical products and treatments for human and animal health. Its brands include Mernova: A licensed producer of cannabis products in Canada for sale under the Ritual brand banner. Sierra Sage Herbs: US-based developer of plant-based, beauty, and personal care brands Green Goo, Southern Butter, and Good Goo. impACTIVE: CBD topical products for athletes. Halucenex: Clinical stage psychedelics research and development operation. Creso Pharma Switzerland: CBD-related research, development, and commercialization.

Melodiol Global Health (ASX:ME1DE) Headlines

No Headlines